Abstracts by keywords: Osteoporosis
The group of people under 60 years of age may already have osteoporotic fractures. The changes in bone density and structure can be ideopathic, postmenopausal, or caused by harmful medication as well as other secondary causes such as hormonal disorders (hyperthyroidism, hyperparathyroidism, hypogonadism, diabetes) (Torner 2015). To date, there have been few separate studies on the frequency of osteoporotic fractures, specifically in middle age (between 50 and 64 years). Against the background of epidemiological information, previous and current work focuses primarily on geriatric clients in the derivation of preventive interventions, for example in secondary prophylaxis (Conley et al. 2019). However, there is little literature on the relevance of health promotion and prevention for working-age patients. In particular, the risk factors known for osteoporosis, drug use, vitamin D and calcium deficiency or psychosocial stress and lack of exercise (DVO; DiPietro et al. 2019; Follis et al. 2019) could play a role in this population. The aim of the present work is to describe the frequency of hospital-diagnosed osteoporotic fractures within the middle age between 50 and 64 years in Germany. Furthermore, the relevance and type of possible preventative measures in this phase of life should be discussed.
04.04.2020
Dementia is a psychiatric disease caused by neurodegeneration, characterized by a progressive loss of cognitive functions, leading to changes in patients' daily lives (WHO, 2015). 47.5 million people worldwide suffer from dementia, and this number is expected to rise to 75.6 million by 2030 and exceed 140 million by 2050 (WHO, 2015). In Germany, dementia affects around 1.2 million people, mainly women and seniors. Approximately 200,000 new cases are diagnosed every year (Tunstall, 2015). The average cost associated with these mental illnesses is more than 43,000 euros per patient per year, with almost 68% of this amount borne by carers and families (Tunstall, 2015). Dementia therefore has a significant impact on patients and their relatives, which underlines the need for specially adapted treatments and appropriate management of the disease in Germany.